Mas...
Buying the UK vaccine maker, which is already a partner with Sanofi on several efforts, is a “logical step”, Wayne Pisano, who heads the drugmaker’s vaccine group, Sanofi Pasteur, says in a statement. By purchasing Acambis, Sanofi gains a smallpox vaccine that was contracted by the US government for $425 million.
Sanofi is the world’s biggest maker of influenza vaccines and last month announced plans to open a $157 million plant in France, citing projections that demand for immunizations will double by 2016.
No hay comentarios:
Publicar un comentario